Lenalidomide Therapy In Previously Untreated, Advanced Stage Indolent Lymphoma
Withdrawn prior to enrolment
Phase of Trial: Phase I/II
Latest Information Update: 29 Sep 2015
At a glance
- Drugs Lenalidomide (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 24 Sep 2015 Status changed from discontinued to withdrawn prior to enrolment,as reported by ClinicalTrials.gov.
- 22 Sep 2015 Status changed from withdrawn prior to enrolment to discontinued as reported by ClinicalTrials.gov.
- 05 Mar 2015 Planned End Date changed from 1 Aug 2012 to 1 May 2011 as reported by ClinicalTrials.gov.